Enhanced antifungal activity of voriconazole-loaded nanostructured lipid carriers against Candida albicans with a dimorphic switching model

Baocheng Tian,1 Qi Yan,1 Juan Wang,1 Chen Ding,2 Sixiang Sai1 1School of Pharmacy, Binzhou Medical University, Yantai, 2College of Life and Health Science, Northeastern University, Shenyang, People’s Republic of China Abstract: Candida commonly adheres to implanted medical devices and fo...

Full description

Bibliographic Details
Main Authors: Tian B, Yan Q, Wang J, Ding C, Sai S
Format: Article
Language:English
Published: Dove Medical Press 2017-09-01
Series:International Journal of Nanomedicine
Subjects:
Online Access:https://www.dovepress.com/enhanced-antifungal-activity-of-voriconazole-loaded-nanostructured-lip-peer-reviewed-article-IJN
_version_ 1818695495594278912
author Tian B
Yan Q
Wang J
Ding C
Sai S
author_facet Tian B
Yan Q
Wang J
Ding C
Sai S
author_sort Tian B
collection DOAJ
description Baocheng Tian,1 Qi Yan,1 Juan Wang,1 Chen Ding,2 Sixiang Sai1 1School of Pharmacy, Binzhou Medical University, Yantai, 2College of Life and Health Science, Northeastern University, Shenyang, People’s Republic of China Abstract: Candida commonly adheres to implanted medical devices and forms biofilms. Due to the minimal activity of current antifungals against biofilms, new drugs or drug-delivery systems to treat these persistent infections are urgently needed. In the present investigation, voriconazole-loaded nanostructured lipid carriers (Vrc-NLCs) were formulated for enhanced drug-delivery efficiency to C. albicans to increase the antifungal activity of Vrc and to improve the treatment of infectious Candida diseases. Vrc-NLCs were prepared by a hot-melt, high-pressure homogenization method, and size distribution, ζ-potential, morphology, drug-encapsulation efficiency, drug loading, and physical stability were characterized. The antifungal activity of Vrc-NLCs in vitro was tested during planktonic and biofilm growth in C. albicans. The mean particle size of the Vrc-NLCs was 45.62±0.53 nm, and they exhibited spheroid-like morphology, smooth surfaces, and ζ-potential of -0.69±0.03 mV. Encapsulation efficiency and drug loading of Vrc-NLCs were 75.37%±2.65% and 3.77%±0.13%, respectively. Physical stability results revealed that despite the low measured ζ-potential, the dispersion of the Vrc-NLCs was stable during their 3-week storage at 4°C. The minimum inhibitory concentration of Vrc-NLCs was identical to that of Vrc. However, the inhibition rate of Vrc-NLCs at lower concentrations was significantly higher than that of Vrc during planktonic growth in C. albicans in yeast-extract peptone dextrose medium. Surprisingly, Vrc-NLCs treatment reduced cell density in biofilm growth in C. albicans and induced more switches form hyphal cells to yeast cells compared with Vrc treatment. In conclusion, Vrc-NLCs maintain antifungal activity of Vrc and increase antifungal drug-delivery efficiency to C. albicans. Therefore, Vrc-NLCs will greatly contribute to the treatment of infectious diseases caused by C. albicans. Keywords: antifungal activity, Candida albicans, voriconazole, nanostructured lipid carriers, biofilms
first_indexed 2024-12-17T13:46:23Z
format Article
id doaj.art-c79b4bc83dab40deacf466668d552f6b
institution Directory Open Access Journal
issn 1178-2013
language English
last_indexed 2024-12-17T13:46:23Z
publishDate 2017-09-01
publisher Dove Medical Press
record_format Article
series International Journal of Nanomedicine
spelling doaj.art-c79b4bc83dab40deacf466668d552f6b2022-12-21T21:46:09ZengDove Medical PressInternational Journal of Nanomedicine1178-20132017-09-01Volume 127131714134877Enhanced antifungal activity of voriconazole-loaded nanostructured lipid carriers against Candida albicans with a dimorphic switching modelTian BYan QWang JDing CSai SBaocheng Tian,1 Qi Yan,1 Juan Wang,1 Chen Ding,2 Sixiang Sai1 1School of Pharmacy, Binzhou Medical University, Yantai, 2College of Life and Health Science, Northeastern University, Shenyang, People’s Republic of China Abstract: Candida commonly adheres to implanted medical devices and forms biofilms. Due to the minimal activity of current antifungals against biofilms, new drugs or drug-delivery systems to treat these persistent infections are urgently needed. In the present investigation, voriconazole-loaded nanostructured lipid carriers (Vrc-NLCs) were formulated for enhanced drug-delivery efficiency to C. albicans to increase the antifungal activity of Vrc and to improve the treatment of infectious Candida diseases. Vrc-NLCs were prepared by a hot-melt, high-pressure homogenization method, and size distribution, ζ-potential, morphology, drug-encapsulation efficiency, drug loading, and physical stability were characterized. The antifungal activity of Vrc-NLCs in vitro was tested during planktonic and biofilm growth in C. albicans. The mean particle size of the Vrc-NLCs was 45.62±0.53 nm, and they exhibited spheroid-like morphology, smooth surfaces, and ζ-potential of -0.69±0.03 mV. Encapsulation efficiency and drug loading of Vrc-NLCs were 75.37%±2.65% and 3.77%±0.13%, respectively. Physical stability results revealed that despite the low measured ζ-potential, the dispersion of the Vrc-NLCs was stable during their 3-week storage at 4°C. The minimum inhibitory concentration of Vrc-NLCs was identical to that of Vrc. However, the inhibition rate of Vrc-NLCs at lower concentrations was significantly higher than that of Vrc during planktonic growth in C. albicans in yeast-extract peptone dextrose medium. Surprisingly, Vrc-NLCs treatment reduced cell density in biofilm growth in C. albicans and induced more switches form hyphal cells to yeast cells compared with Vrc treatment. In conclusion, Vrc-NLCs maintain antifungal activity of Vrc and increase antifungal drug-delivery efficiency to C. albicans. Therefore, Vrc-NLCs will greatly contribute to the treatment of infectious diseases caused by C. albicans. Keywords: antifungal activity, Candida albicans, voriconazole, nanostructured lipid carriers, biofilmshttps://www.dovepress.com/enhanced-antifungal-activity-of-voriconazole-loaded-nanostructured-lip-peer-reviewed-article-IJNantifungal activityCandida albicansvoriconazolenanostructured lipid carriersbiofilm.
spellingShingle Tian B
Yan Q
Wang J
Ding C
Sai S
Enhanced antifungal activity of voriconazole-loaded nanostructured lipid carriers against Candida albicans with a dimorphic switching model
International Journal of Nanomedicine
antifungal activity
Candida albicans
voriconazole
nanostructured lipid carriers
biofilm.
title Enhanced antifungal activity of voriconazole-loaded nanostructured lipid carriers against Candida albicans with a dimorphic switching model
title_full Enhanced antifungal activity of voriconazole-loaded nanostructured lipid carriers against Candida albicans with a dimorphic switching model
title_fullStr Enhanced antifungal activity of voriconazole-loaded nanostructured lipid carriers against Candida albicans with a dimorphic switching model
title_full_unstemmed Enhanced antifungal activity of voriconazole-loaded nanostructured lipid carriers against Candida albicans with a dimorphic switching model
title_short Enhanced antifungal activity of voriconazole-loaded nanostructured lipid carriers against Candida albicans with a dimorphic switching model
title_sort enhanced antifungal activity of voriconazole loaded nanostructured lipid carriers against candida albicans with a dimorphic switching model
topic antifungal activity
Candida albicans
voriconazole
nanostructured lipid carriers
biofilm.
url https://www.dovepress.com/enhanced-antifungal-activity-of-voriconazole-loaded-nanostructured-lip-peer-reviewed-article-IJN
work_keys_str_mv AT tianb enhancedantifungalactivityofvoriconazoleloadednanostructuredlipidcarriersagainstcandidaalbicanswithadimorphicswitchingmodel
AT yanq enhancedantifungalactivityofvoriconazoleloadednanostructuredlipidcarriersagainstcandidaalbicanswithadimorphicswitchingmodel
AT wangj enhancedantifungalactivityofvoriconazoleloadednanostructuredlipidcarriersagainstcandidaalbicanswithadimorphicswitchingmodel
AT dingc enhancedantifungalactivityofvoriconazoleloadednanostructuredlipidcarriersagainstcandidaalbicanswithadimorphicswitchingmodel
AT sais enhancedantifungalactivityofvoriconazoleloadednanostructuredlipidcarriersagainstcandidaalbicanswithadimorphicswitchingmodel